ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC])
C8278/2022/BP/US-CA
Phase 2 small_molecule completed
Quick answer
ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) for Pain is a Phase 2 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed